Literature DB >> 22913984

Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation.

Laleh Sistani1, Patricia Q Rodriguez, Kjell Hultenby, Mathias Uhlen, Christer Betsholtz, Hannu Jalanko, Karl Tryggvason, Annika Wernerson, Jaakko Patrakka.   

Abstract

The podocyte has a central role in the glomerular filtration barrier typified by a sophisticated morphology of highly organized primary (major) and secondary (foot) processes. The molecular makeup of foot processes is well characterized, but that of major processes is poorly known. Previously, we profiled the glomerular transcriptome through large-scale sequencing and microarray profiling. Unexpectedly, the survey found expression of three neuronal proteins (Huntingtin interacting protein 1 (Hip1), neurofascin (Nfasc), and olfactomedin-like 2a (Olfml2a)), all enriched in the glomerulus. These proteins were expressed exclusively by podocytes, wherein they localized to major processes as verified by RT-PCR, western blotting, immunofluorescence, and immunoelectron microscopy. During podocyte development, these proteins colocalized with vimentin, confirming their association with major processes. Using immunohistochemistry, we found coexpression of Hip1 and Olfml2a along with the recognized podocyte markers synaptopodin and Pdlim2 in glomerular crescents of human kidneys, indicating the presence of podocytes in these lesions. Thus, three neuronal proteins are highly expressed in podocyte major process. Using these new markers we found that podocytes contribute to the formation of glomerular crescents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913984     DOI: 10.1038/ki.2012.321

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome.

Authors:  Estelle Colin; Evelyne Huynh Cong; Géraldine Mollet; Agnès Guichet; Olivier Gribouval; Christelle Arrondel; Olivia Boyer; Laurent Daniel; Marie-Claire Gubler; Zelal Ekinci; Michel Tsimaratos; Brigitte Chabrol; Nathalie Boddaert; Alain Verloes; Arnaud Chevrollier; Naig Gueguen; Valérie Desquiret-Dumas; Marc Ferré; Vincent Procaccio; Laurence Richard; Benoit Funalot; Anne Moncla; Dominique Bonneau; Corinne Antignac
Journal:  Am J Hum Genet       Date:  2014-11-13       Impact factor: 11.025

2.  MiR-29b expression is altered in crescent formation of HSPN and accelerates Ang II-induced mesangial cell activation.

Authors:  Shan Cheng; Chun-Hua Zhu; Ai-Hua Zhang; Song-Ming Huang
Journal:  World J Pediatr       Date:  2019-10-19       Impact factor: 2.764

Review 3.  APOL1 Kidney Disease Risk Variants: An Evolving Landscape.

Authors:  Patrick D Dummer; Sophie Limou; Avi Z Rosenberg; Jurgen Heymann; George Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

4.  Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.

Authors:  Xiaojie Ma; Angelina Schwarz; Sonia Zambrano Sevilla; Anna Levin; Kjell Hultenby; Annika Wernerson; Mark Lal; Jaakko Patrakka
Journal:  J Am Soc Nephrol       Date:  2018-04-10       Impact factor: 10.121

5.  Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM.

Authors:  Ljubica Perisic Matic; Urszula Rykaczewska; Anton Razuvaev; Maria Sabater-Lleal; Mariette Lengquist; Clint L Miller; Ida Ericsson; Samuel Röhl; Malin Kronqvist; Silvia Aldi; Joelle Magné; Valentina Paloschi; Mattias Vesterlund; Yuhuang Li; Hong Jin; Maria Gonzalez Diez; Joy Roy; Damiano Baldassarre; Fabrizio Veglia; Steve E Humphries; Ulf de Faire; Elena Tremoli; Jacob Odeberg; Vladana Vukojević; Janne Lehtiö; Lars Maegdefessel; Ewa Ehrenborg; Gabrielle Paulsson-Berne; Göran K Hansson; Jan H N Lindeman; Per Eriksson; Thomas Quertermous; Anders Hamsten; Ulf Hedin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

6.  TWEAK/Fn14 system and crescent formation in IgA nephropathy.

Authors:  Yohei Sasaki; Yoshio Shimizu; Yusuke Suzuki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2015-03-14       Impact factor: 2.388

7.  Olfactomedin-like 2 A and B (OLFML2A and OLFML2B) expression profile in primates (human and baboon).

Authors:  Diana Cristina Pérez-Ibave; Rafael González-Alvarez; Margarita de La Luz Martinez-Fierro; Gabriel Ruiz-Ayma; Maricela Luna-Muñoz; Laura Elia Martínez-De-Villarreal; María De Lourdes Garza-Rodríguez; Diana Reséndez-Pérez; Jibran Mohamed-Noriega; Raquel Garza-Guajardo; Víctor Manuel Bautista-De-Lucío; Karim Mohamed-Noriega; Oralia Barboza-Quintana; Carlos Arámburo-De-La-Hoz; Hugo Alberto Barrera-Saldaña; Irám Pablo Rodríguez-Sánchez
Journal:  Biol Res       Date:  2016-11-08       Impact factor: 5.612

8.  Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.

Authors:  Khedidja Bouachi; Anissa Moktefi; Shao-Yu Zhang; Julie Oniszczuk; Kelhia Sendeyo; Philippe Remy; Vincent Audard; Andre Pawlak; Mario Ollero; Djillali Sahali
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

9.  Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement.

Authors:  Angelina Schwarz; Katja Möller-Hackbarth; Lwaki Ebarasi; David Unnersjö Jess; Sonia Zambrano; Hans Blom; Annika Wernerson; Mark Lal; Jaakko Patrakka
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

10.  LIM-Nebulette Reinforces Podocyte Structural Integrity by Linking Actin and Vimentin Filaments.

Authors:  Xuhua Ge; Tao Zhang; Xiaoxia Yu; Alecia N Muwonge; Nanditha Anandakrishnan; Nicholas J Wong; Jonathan C Haydak; Jordan M Reid; Jia Fu; Jenny S Wong; Smiti Bhattacharya; Christina M Cuttitta; Fang Zhong; Ronald E Gordon; Fadi Salem; William Janssen; James C Hone; Aihua Zhang; Hong Li; John C He; G Luca Gusella; Kirk N Campbell; Evren U Azeloglu
Journal:  J Am Soc Nephrol       Date:  2020-07-31       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.